Evidence map›Paper›PMID 35811629›Full record

ArticleJournal of pharmaceutical analysis2022

Compatibility and stability studies involving polymers used in fused deposition modeling 3D printing of medicines.

Ihatanderson A Silva, Ana Luiza Lima, Tais Gratieri, Guilherme M Gelfuso, Livia L Sa-Barreto, Marcilio Cunha-Filho

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Chemical Stability Study of HMolecules (Basel, Switzerland) · 2022
    Article
  10. 3D printing of pharmaceuticals for disease treatment.Frontiers in medical technology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ihatanderson A SilvaLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Ana Luiza LimaLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Tais GratieriLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Guilherme M GelfusoLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Livia L Sa-BarretoFaculty of Ceilandia, University of Brasilia (UnB), 72220-900, Brasília, DF, Brazil.
Marcilio Cunha-FilhoLaboratory of Food, Drug, and Cosmetics (LTMAC), School of Health Sciences, University of Brasilia, 70910-900, Brasília, DF, Brazil.
Universidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the challenges in developing three-dimensional printed medicines is related to their stability due to the manufacturing conditions involving high temperatures. This work proposed a new protocol for preformulation studies simulating thermal processing and aging of the printed medicines, tested regarding their morphology and thermal, crystallographic, and spectroscopic profiles. Generally, despite the strong drug-polymer interactions observed, the chemical stability of the model drugs was preserved under such conditions. In fact, in the metoprolol and Soluplus® composition, the drug's solubilization in the polymer produced a delay in the drug decomposition, suggesting a protective effect of the matrix. Paracetamol and polyvinyl alcohol mixture, in turn, showed unmistakable signs of thermal instability and chemical decomposition, in addition to physical changes. In the presented context, establishing protocols that simulate processing and storage conditions may be decisive for obtaining stable pharmaceutical dosage forms using three-dimensional printing technology.

Indexed as

Drug-polymer compatibilityHot-melt extrusionPreformulationThermal analysisThree-dimensional printing

Identifiers

PMID35811629
PMCPMC9257448
OpenAlexW3198939446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.